Search

everythinglearnresearchcommunity

for

Search:↓

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

The protein ARA70/ELE1 is involved in male pattern baldness, and lower levels of its short form may lead to hair thinning.

COVID-19 may harm male fertility and damage the reproductive system.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

Minocycline may cause hair loss by increasing DHT levels, but finasteride can help counteract this effect.

Possible link between androgens and COVID-19 severity; more research needed.

A 17-year-old female with adrenogenital syndrome produces very high levels of androgens, which prevent complete feminization despite high estrogen doses.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

Flutamide and finasteride reduced sex hormones in pregnant hyenas, but increased them in males.

Dutasteride shows promise as a potential treatment for Parkinson's disease.

Neurosteroids like neuro-estrogen and neuro-androgen are crucial for brain function and can improve cognition and protect against aging-related decline.

Platycladi Cacumen may help treat hair loss by targeting specific proteins and pathways.

Combined finasteride and anastrozole therapy effectively treats BPH, influenced by hormone imbalances and genetics.

People with hair loss have more androgen receptors and enzymes in certain follicles, with men and women showing different patterns.

Higher levels of unbound testosterone are linked to increased insulin resistance, especially in women with polycystic ovary syndrome.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

Baldness caused by male hormones in female-to-male transsexuals doesn't increase the risk of heart disease.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

TGF-β1 increases androgen receptor activity in hair loss, but Hic-5/ARA55 can counter this effect.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

Finger length ratios don't predict baldness in men.